The global antisense and RNAi therapeutics market, valued at USD 5.10 Billion in 2024, is propelled by increased genetic research funding and rising prevalence of genetic disorders. With a projected CAGR of 18.70% from 2025 to 2034, the market is expected to reach USD 28.32 Billion, reflecting significant growth in precision medicine. https://www.expertmarketresearch.com/reports/antisense-and-rnai-therapeutics-market